At Ares Genetics, we are developing a rapid, DNA-based test for universal pathogen diagnostics and drug response prediction.
Complementing our research use only testing services, we are working on the development of diagnostic testing services from native patient samples and plan to eventually offer an IVD test kit for use by any laboratory worldwide.
Designed to detect any pathogen and antibiotic resistance using a single, standardized test starting from any native patient sample.
Informed by a global and continuously updated reference database (ARESdb) to reflect epidemiology of microbial infections and resistance evolution.
Compatible with turn-around-times of less than 6 hours at launch and 1-2 hours mid- to long term.
Our digital health platform allows for connected research & epidemiology solutions as well as tracking of emerging antibiotic resistance over time and space.
With our partner network, we conveniently offer epidemiology sequencing services and reporting starting from clinical isolates, as well as cloud-based data interpretation solutions starting from next-generation sequencing raw data.
Additionally, we are currently preparing the set up of the first European reference laboratory for next-generation sequencing molecular microbiology solutions in Vienna, Austria to offer most convenient and rapid sample-to-answer testing services by overnight shipping from major European hubs.
Similarly, we are planning to set up reference laboratories in the US and China either as Ares Genetics or with partners.